BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15036158)

  • 1. Structural change in response to ligand binding.
    McCammon MG; Robinson CV
    Curr Opin Chem Biol; 2004 Feb; 8(1):60-5. PubMed ID: 15036158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of MS in structure elucidation of protein-nucleic acid complexes.
    Gordiyenko Y; Robinson CV
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):723-31. PubMed ID: 18631148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
    Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
    J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based approaches to protein-ligand interactions.
    Schermann SM; Simmons DA; Konermann L
    Expert Rev Proteomics; 2005 Aug; 2(4):475-85. PubMed ID: 16097882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospray mass spectrometry to study drug-nucleic acids interactions.
    Rosu F; De Pauw E; Gabelica V
    Biochimie; 2008 Jul; 90(7):1074-87. PubMed ID: 18261993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking structural change with functional regulation-insights from mass spectrometry.
    Morgner N; Robinson CV
    Curr Opin Struct Biol; 2012 Feb; 22(1):44-51. PubMed ID: 22300497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding constant determination of high-affinity protein-ligand complexes by electrospray ionization mass spectrometry and ligand competition.
    Wortmann A; Jecklin MC; Touboul D; Badertscher M; Zenobi R
    J Mass Spectrom; 2008 May; 43(5):600-8. PubMed ID: 18074334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of molecular interaction within biological macromolecular complexes by mass spectrometry.
    Akashi S
    Med Res Rev; 2006 May; 26(3):339-68. PubMed ID: 16463282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling the activity of peptides and proteins with smart nucleic acid-protein hybrids.
    Röglin L; Seitz O
    Org Biomol Chem; 2008 Nov; 6(21):3881-7. PubMed ID: 18931789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of protein-ligand interactions by mass spectrometry.
    Sinz A
    ChemMedChem; 2007 Apr; 2(4):425-31. PubMed ID: 17299828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protocol for the combined sub-fractionation and delipidation of lipid binding proteins using hydrophobic interaction chromatography.
    Velkov T; Lim ML; Capuano B; Prankerd R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(2):238-46. PubMed ID: 18456580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes.
    Hyung SJ; Robinson CV; Ruotolo BT
    Chem Biol; 2009 Apr; 16(4):382-90. PubMed ID: 19389624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-nucleic acid complexes and the role of mass spectrometry in their structure determination.
    Park AY; Robinson CV
    Crit Rev Biochem Mol Biol; 2011 Apr; 46(2):152-64. PubMed ID: 21417597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alpha helices interacting with nucleic acids.
    Sreekanth R; Pattabhi V; Rajan SS
    Comput Biol Chem; 2008 Oct; 32(5):378-81. PubMed ID: 18667362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes.
    Hofstadler SA; Sannes-Lowery KA
    Nat Rev Drug Discov; 2006 Jul; 5(7):585-95. PubMed ID: 16816839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural artifacts in protein-ligand X-ray structures: implications for the development of docking scoring functions.
    Søndergaard CR; Garrett AE; Carstensen T; Pollastri G; Nielsen JE
    J Med Chem; 2009 Sep; 52(18):5673-84. PubMed ID: 19711919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1.
    Bovet C; Ruff M; Eiler S; Granger F; Wenzel R; Nazabal A; Moras D; Zenobi R
    Anal Chem; 2008 Oct; 80(20):7833-9. PubMed ID: 18778086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online magnetic bead dynamic protein-affinity selection coupled to LC-MS for the screening of pharmacologically active compounds.
    Jonker N; Kretschmer A; Kool J; Fernandez A; Kloos D; Krabbe JG; Lingeman H; Irth H
    Anal Chem; 2009 Jun; 81(11):4263-70. PubMed ID: 19476387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.